Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © The Author(s) 2023. This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
| Keywords: | Axial spondyloarthritis; Ankylosing spondylitis; Biological disease-modifying antirheumatic drugs (bDMARDs); Therapeutics |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds) The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Institute of Rheumatology & Musculoskeletal Medicine (LIRMM) (Leeds) |
| Funding Information: | Funder Grant number Wellcome Trust R127002 |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 06 Feb 2023 15:44 |
| Last Modified: | 25 Jun 2023 23:14 |
| Status: | Published |
| Publisher: | Springer |
| Identification Number: | 10.1007/s11926-023-01097-7 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:195844 |
CORE (COnnecting REpositories)
CORE (COnnecting REpositories)